Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Phathom Pharmaceuticals I...

    NASDAQ: PHAT · Real-Time Price · USD
    10.60
    -0.04 (-0.38%)
    At close: Jun 16, 2025, 3:59 PM
    10.66
    0.57%
    Pre-market: Jun 17, 2025, 04:00 AM EDT

    Phathom Pharmaceuticals Statistics

    Share Statistics

    Phathom Pharmaceuticals has 69.81M shares outstanding. The number of shares has increased by 18.97% in one year.

    Shares Outstanding

    n/a
    		 69.81M

    Shares Change (YoY)

    n/a
    		 18.97%

    Shares Change (QoQ)

    n/a
    		 1.84%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 37.85M

    Failed to Deliver (FTD) Shares

    n/a
    		 195,287

    FTD / Avg. Volume

    n/a
    		 7.19%

    Short Selling Information

    The latest short interest is 10.98M, so 15.77% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 10.98M

    Short % of Shares Out

    n/a
    		 15.77%

    Short % of Float

    n/a
    		 26.35%

    Short Ratio (days to cover)

    n/a
    		 9.97

    Valuation Ratios

    The PE ratio is -1.53 and the forward PE ratio is -33.3. Phathom Pharmaceuticals's PEG ratio is -0.04.

    PE Ratio

    n/a
    		 -1.53

    Forward PE

    n/a
    		 -33.3

    PS Ratio

    n/a
    		 9.28

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 -2.02

    P/FCF Ratio

    n/a
    		 -1.92

    PEG Ratio

    n/a
    		 -0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Phathom Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.2, with a Debt / Equity ratio of -0.8.

    Current Ratio

    n/a
    		 4.2

    Quick Ratio

    n/a
    		 4.16

    Debt / Equity

    n/a
    		 -0.8

    Debt / EBITDA

    n/a
    		 -0.77

    Debt / FCF

    n/a
    		 -0.76

    Interest Coverage

    n/a
    		 -3.85

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $129,395.78

    Profits Per Employee

    n/a
    		 $-782,964.87

    Employee Count

    n/a
    		 427

    Asset Turnover

    n/a
    		 0.15

    Inventory Turnover

    n/a
    		 2.49

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -9.4% in the last 52 weeks. The beta is 0.1, so Phathom Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.1

    52-Week Price Change

    n/a
    		 -9.4%

    50-Day Moving Average

    n/a
    		 4.76

    200-Day Moving Average

    n/a
    		 9.1

    Relative Strength Index (RSI)

    n/a
    		 86.4

    Average Volume (20 Days)

    n/a
    		 2,717,104

    Income Statement

    In the last 12 months, Phathom Pharmaceuticals had revenue of 55.25M and earned -334.33M in profits. Earnings per share was -5.29.

    Revenue

    n/a
    		 55.25M

    Gross Profit

    n/a
    		 47.28M

    Operating Income

    n/a
    		 -277.47M

    Net Income

    n/a
    		 -334.33M

    EBITDA

    n/a
    		 -261.52M

    EBIT

    n/a
    		 -262.32M

    Earnings Per Share (EPS)

    n/a
    		 -5.29
    Full Income Statement

    Balance Sheet

    The company has 297.26M in cash and 201.91M in debt, giving a net cash position of 95.35M.

    Cash & Cash Equivalents

    n/a
    		 297.26M

    Total Debt

    n/a
    		 201.91M

    Net Cash

    n/a
    		 95.35M

    Retained Earnings

    n/a
    		 -1.26B

    Total Assets

    n/a
    		 294.21M

    Working Capital

    n/a
    		 190.87M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -266.77M and capital expenditures 0, giving a free cash flow of -266.9M.

    Operating Cash Flow

    n/a
    		 -266.77M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -266.9M

    FCF Per Share

    n/a
    		 -4.22
    Full Cash Flow Statement

    Margins

    Gross margin is 85.57%, with operating and profit margins of -502.18% and -605.09%.

    Gross Margin

    n/a
    		 85.57%

    Operating Margin

    n/a
    		 -502.18%

    Pretax Margin

    n/a
    		 -605.09%

    Profit Margin

    n/a
    		 -605.09%

    EBITDA Margin

    n/a
    		 -473.33%

    EBIT Margin

    n/a
    		 -502.18%

    FCF Margin

    n/a
    		 -483.07%

    Dividends & Yields

    PHAT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PHAT is $17, which is 60.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $17

    Price Target Difference

    n/a
    		 60.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -8.21

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist